Chronic fatigue syndrome (CFS) is a clinical diagnosis based on over 6 months of new and significant fatigue that is not relieved by adequate rest and sleep and which is exacerbated in a delayed fashion by any physical, mental and emotional over-activity. It is frequently accompanied by non-restorative sleep, arthralgia, myalgia, autonomic dysfunction, headaches, hypersensitivity to lights and sounds and impaired concentration and short term memory. Many patients date the onset of their symptoms after a viral or other infection and often during a period of increased psychosocial stress. Routine tests for haematological and biochemical dysfunction, endocrinopathy, inflammation, autoimmunity and immune deficiency are normal and there are presently no diagnostic tests. Indeed, diagnosis is frequently based on patients fulfilling the Canadian [1], international [2] or institute of medicine [
3] CFS/ME criteria, with normal blood tests and in the absence of a medical or psychological cause of the fatigue. Interestingly, patients with CFS frequently report recurrent infections and especially upper respiratory tract symptoms such as sore throat with associated cervical lymphadenopathy as well as recurrent ‘colds’ or viral-type symptoms. Importantly, the presence of these symptoms forms part of the diagnostic criteria for CFS [
4,
5]. We have previously found significant abnormalities of B cells [
6] and T cells [
7] in patients with CFS who otherwise had normal serum immunoglobulins. This included increased numbers of naïve B cells and transitional B cells but reduced numbers of plasmablasts [
6]. There is also a significant literature suggesting a subtle impairment of cellular immune function in patients with CFS [
8,
9].